Type of Study:
The purpose of this study is to evaluate the contraceptive efficacy and safety of NOMAC-E2 Combined Oral Contraceptive in premenopausal females.

Study Length:
14 Months

Target Age/Sex:
18 - 35 years old - Female

Benefits:
Participants will receive at no cost: medication and any other study related procedures and may also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov

Staus: Enrolling

Description:

Potential participants must be sexually active and engage in heterosexual vaginal intercourse at least once per month with a partner who is not known to be subfertile, sterilized, or infertile, and should not routinely use any other form of contraception.

To learn more, fill out the form or call 208-557-2991 or 208-557-2924.

Information Request

Information Request

How did you hear about this study?